Global Infectious Diseases Diagnostics Market Size Study, by Product & Service (Assays, Kits, Reagents, Instruments, Services & Software) by Technology (Immunodiagnostics, Clinic Microbiology, DNA Microarray) by Disease Type (Tuberculosis, HAIS, HIV, Hepatitis) by End Use (Hospital, Physician Offices, Others) by Regional Forecasts 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Infectious Diseases Diagnostics Market valued approximately USD 14 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2017-2025. Growing prevalence of infectious diseases across the globe, increasing funding for research for infectious disease diagnostics and the change in focus from centralized laboratories to decentralized point-of-care testing. Infectious disease diagnostics are several techniques used by professionals to diagnose and detect pathogens in human samples such as a throat swab, urine, serum, blood, and stool.

Global Infectious Diseases Diagnostics Market to reach USD 23.65 billion by 2025.The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:

  • Assays, Kits, Reagents
  • Instruments
  • Services & Software

By Technology:

  • Immunodiagnostics
  • Clinic Microbiology
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing
  • DNA Microarray
  • Other Technologies

By Diseases Type:

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Chlamydia Trachomatis Genital Infection & Gonorrhea
  • Hospital-Acquired Infection (HAIS)
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases

By End-Use:

  • Hospitals/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Academic/Research Institutes
  • Others

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Bio-Rad Laboratories, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Infectious Diseases Diagnostics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.           Global Infectious Diseases Diagnostics Market Definition and Scope

1.1.         Research Objective

1.2.         Market Definition

1.3.         Scope of The Study

1.4.         Years Considered for The Study

1.5.         Currency Conversion Rates

1.6.         Report Limitation

Chapter 2.           Research Methodology

2.1.         Research Process

2.1.1.     Data Mining

2.1.2.     Analysis

2.1.3.     Market Estimation

2.1.4.     Validation

2.1.5.     Publishing

2.2.         Research Assumption

Chapter 3.           Executive Summary

3.1.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2.         Key Trends

Chapter 4.           Global Infectious Diseases Diagnostics Market Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.2.1.     Porter’s 5 Force Model

4.2.2.     PEST Analysis

4.2.3.     Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.           Global Infectious Diseases Diagnostics Market, By Product & Service

5.1.         Market Snapshot

5.2.         Market Performance – Potential Model

5.3.         Global Infectious Diseases Diagnostics Market, Sub Segment Analysis

5.3.1.     Assays, Kits, Reagents

5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.     Instruments

5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.     Services & Software

5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6.           Global Infectious Diseases Diagnostics Market, By Technology

6.1.         Market Snapshot

6.2.         Market Performance – Potential Model

6.3.         Global Infectious Diseases Diagnostics Market, Sub Segment Analysis

6.3.1.     Immunodiagnostics

6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.     Clinic Microbiology

6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.     Polymerase Chain Reaction (PCR)

6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.     Isothermal Nucleic Acid Amplification Technology (INAAT)

6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.     DNA Sequencing & Next-Generation Sequencing

6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.6.     DNA Microarray

6.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.7.     Other technologies

6.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7.           Global Infectious Diseases Diagnostics Market, By Disease Type

7.1.         Market Snapshot

7.2.         Market Performance – Potential Model

7.3.         Global Infectious Diseases Diagnostics Market, Sub Segment Analysis

7.3.1.     Hepatitis

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.     Human Immunodeficiency Virus (HIV)

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.     Chlamydia Trachomatis Genital Infection & Gonorrhoea (CT/NG)

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.     Hospital-Acquired Infection (HAIS)

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.     Tuberculosis

7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.     Influenza

7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.     Other Infectious Diseases

7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8.           Global Infectious Diseases Diagnostics Market, By End-Use

8.1.         Market Snapshot

8.2.         Market Performance – Potential Model

8.3.         Global Infectious Diseases Diagnostics Market, Sub Segment Analysis

8.3.1.     Hospital/Clinical Laboratories

8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.     Reference Laboratories

8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.     Physician Offices

8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.     Academic/ Research Institutes

8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.5.     Other End-Use.

8.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9.           Global Infectious Diseases Diagnostics Market, by Regional Analysis

9.1.         Infectious Diseases Diagnostics Market, Regional Market Snapshot (2015-2025)

9.2.         North America Infectious Diseases Diagnostics Market Snapshot

9.2.1.     U.S.

9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.     Canada

9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.2.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.         Europe Infectious Diseases Diagnostics Market Snapshot

9.3.1.     U.K.

9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.     Germany

9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.     France

9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.3.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.     Rest of Europe

9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.3.4.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.         Asia Infectious Diseases Diagnostics Market Snapshot

9.4.1.     China

9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.     India

9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.     Japan

9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.     Rest of Asia Pacific

9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.4.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.         Latin America Infectious Diseases Diagnostics Market Snapshot

9.5.1.     Brazil

9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.     Mexico

9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.5.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.         Rest of The World

9.6.1.     South America

9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.1.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.     Middle East and Africa

9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

9.6.2.5. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 10.         Competitive Intelligence

10.1.      Company Market Share (Subject to Data Availability)

10.2.      Top Market Strategies

10.3.      Company Profiles

10.3.1.   Abbott Laboratories

10.3.1.1.               Overview

10.3.1.2.               Financial (Subject to Data Availability)

10.3.1.3.               Product Summary

10.3.1.4.               Recent Developments

10.3.2.   Becton, Dickinson & Company

10.3.3.   Bio-Rad Laboratories

10.3.4.   Danaher Corporation

10.3.5.   Diasorin

10.3.6.   Luminex

10.3.7.   Meridian Bioscience

10.3.8.   Quidel

10.3.9.   Roche Diagnostics

10.3.10.                Siemens AG

The research for global Infectious Diseases Diagnostics Market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand for Infectious Diseases Diagnostics across various end user.

The revenue for global Infectious Diseases Diagnostics market is calculated as sum market sizes of different segments such as product and service, technology, diseases type, and regions. Further, some other key data points considered to calculate the revenue for global Infectious Diseases Diagnostics market include:

  • Revenues from key companies
  • Key company market share analysis
  • Consumer spending analysis
  • Regional export and import analysis
  • Sales revenue generated by various applications in different geographies

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts.  


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…